GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum
GeneDx Holdings Corp. is positioned as a leader in advanced exome and genome diagnostics, leveraging its expanding rare disease dataset.Fourth quarter preliminary results met guidance but did not exceed it
admin